SLU-PP-332

SLU-PP-332, a synthetic small-molecule drug, has been examined in laboratory research as a pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ). It is utilized in preclinical research to study mitochondrial biogenesis, oxidative metabolism, and skeletal muscle fiber signaling pathways.